Breastfeeding and mastitis. Empirical treatment based on symptoms and etiological agents;Lactancia materna y mastitis. Tratamiento empírico basado en la sintomatología y los agentes etiológicos

Acta Pediatrica Espanola

Volumn 70, Issue 6, 2012, Pages 255-261

  Carrera, M ^a   Arroyo, R ^b   Mediano, R ^b   Fernandez L ^b   Marin M ^b   Rodriguez J M ^b  

^a Centro de Atención Primaria Silvano   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antibiotics; Mastitis; Nonsteroidal anti inflammatory drugs (NSAIDS); Probiotics; Treatment

Indexed keywords

ANTIBIOTIC SENSITIVITY; BREAST FEEDING; CULTURE TECHNIQUE; MASTITIS; MICROBIOLOGICAL EXAMINATION; MILK; REVIEW; TREATMENT INDICATION;

EID: 84864143637     PISSN: 00016640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Rodríguez JM, Jiménez E, Merino V, Maldonado ML, Marín ML, Fernández L, et al. Microbiota de la leche humana en condiciones fisiológicas. Acta Pediatr Esp. 2008; 66: 77-82. (Pubitemid 351462972)
2. Delgado S, Arroyo R, Jiménez E, Fernández L, Rodríguez JM. Mastitis infecciosas durante la lactancia: un problema infravalorado (I). Acta Pediatr Esp. 2009; 67: 77-84.
3. Jiménez E, Delgado S, Arroyo R, Fernández L, Rodríguez JM. Mastitis infecciosas durante la lactancia: un problema infravalorado (II). Acta Pediatr Esp. 2009; 67: 125-132.
4. Arroyo R, Mediano P, Jiménez E, Delgado S, Fernández L, Marín M, et al. Diagnóstico etiológico de las mastitis infecciosas: propuesta de protocolo para el cultivo de muestras de leche humana. Acta Pediatr Esp. 2011; 69: 276-281.
5. Moazzez A, Kelso RL, Towfigh S, Sohn H, Berne TV, Mason RJ. Breast abscess bacteriologic features in the era of community-acquired methicillin-resistant Staphylococcus aureus epidemics. Arch Surg. 2007; 142: 881-884. (Pubitemid 47437311)
6. Delgado S, Arroyo R, Jiménez E, Herrero E, Del Campo R, Marín M, et al. Staphylococcus epidermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics. BMC Microbiol. 2009; 9: 82.
7. Paviour S, Musaad S, Roberts S, Taylor G, Taylor S, Shore K, et al. Corynebacterium species isolated from patients with mastitis. Clin Infect Dis. 2002; 35: 1.434-1.440.
8. Bercot B, Kannengiesser C, Oudin C, Grandchamp B, Sanson-le Pors MJ, et al. First description of NOD2 variant associated with defective neutrophil responses in a woman with granulomatous mastitis related to corynebacteria. J Clin Microbiol. 2009; 47: 3.034-3.037.
9. Otto M. Staphylococcus epidermidis: the «accidental» pathogen. Nat Rev Microbiol. 2009; 7: 555-567.
10. Rodríguez JM, Dalmau J. Probióticos para el binomio madre-hijo (I). Acta Pediatr Esp. 2007; 65: 452-457.
11. Rodríguez JM, Dalmau J. Probióticos para el binomio madre-hijo (II). Acta Pediatr Esp. 2007; 65: 513-518.
12. Jiménez E, Fernández L, Maldonado A, Martín R, Olivares M, Xaus J, et al. Oral administration of lactobacilli strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl Environ Microbiol. 2008; 74: 4.650-4.655.
13. Arroyo R, Martín V, Maldonado A, Jiménez E, Fernández L, Rodríguez JM. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of lactobacilli isolated from breast milk. Clin Infect Dis. 2010; 50: 1.551-1.558.
14. Singh R, Ray P, Das A, Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother. 2010; 65: 1.955-1.958.
15. Gürpinar AN, Balkan E, Kiliç N, Kiriştioǧlu I, Doǧruyol H. The effects of a fluoroquinolone on the growth and development of infants. J Int Med Res. 1997; 25: 302-306. (Pubitemid 27472759)
16. Dutta S, Chowdhary G, Kumar P, Mukhopadhay K, Narang A. Ciprofloxacin administration to very low birth weight babies has no effect on linear growth in infancy. J Trop Pediatr. 2006; 52: 103-106.
17. Van den Oever HL, Versteegh FG, Thewessen EA, Van den Anker JN, Mouton JW, Neijens HJ. Ciprofloxacin in preterm neonates: case report and review of the literature. Eur J Pediatr. 1998; 157: 843-845. (Pubitemid 28460747)
18. Belet N, Haciomeroglu P, Kucukoduk S. Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections. Biol Neonate. 2004; 85: 263-268. (Pubitemid 38813001)
19. Drossou-Agakidou V, Roilides E, Papakyriakidou-Koliouska P, Agakidis C, Nikolaides N, Sarafidis K, et al. Use of ciprofloxacin in neonatal sepsis: lack of adverse effects up to one year. Pediatr Infect Dis J. 2004; 23: 346-349. (Pubitemid 38508889)
20. Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000; 44: 231-238. (Pubitemid 30060711)
21. Rich M, Deighton L, Roberts L. Clindamycin-resistance in methicillin-resistant Staphylococcus aureus isolated from animals. Vet Microbiol. 2005; 111: 237-240. (Pubitemid 41681689)
22. Luthje P, Schwarz S. Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide-lincosamide resistance phenotypes and genotypes. J Antimicrob Chemother. 2006; 57: 966-969.
23. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, et al. SENTRY Participants Group. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001; 32 Supl 2: 114-132.
24. Vos MC, Ott A, Verbrugh HA. Successful search-and-destroy policy for methicillin-resistant Staphylococcus aureus in The Netherlands. J Clin Microbiol. 2005; 43: 2034.
25. Van Pelt C, Nouwen J, Lugtenburg E, Van der Schee C, De Marie S, Schuijff P, et al. Strict infection control measures do not prevent clonal spread of coagulase negative staphylococci colonizing central venous catheters in neutropenic hemato-oncologic patients. FEMS Immunol Med Microbiol. 2003; 38: 153-158. (Pubitemid 37297840)
26. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001; 9(10): 486-493. (Pubitemid 32939356)
27. Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, Daum RS, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002; 46: 1.147-1.152.
28. Miragaia M, Couto I, De Lencastre H. Genetic diversity among methicillin-resistant Staphylococcus epidermidis (MRSE). Microb Drug Resist. 2005; 11: 83-93. (Pubitemid 40705815)
29. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase negative staphylococci. N Engl J Med. 1987; 316: 927-931. (Pubitemid 17041985)
30. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am. 2009; 23: 73-98.
31. Raad I, Hanna H, Maki D. Intravascular catheter related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007; 7: 645-657.
32. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1.318-1.322.
33. O'Toole G, Kaplan HB, Kolter R, Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Sci Annu Rev Microbiol. 2000; 54: 49-79.
34. Yao Y, Sturdevant DE, Otto M. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol soluble modulins in formation of biofilms. J Infect Dis. 2005; 191: 289-298. (Pubitemid 40096388)
35. Khardori N, Yassien M, Wilson K. Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents. J Ind Microbiol. 1995; 15: 148-151.
36. Duguid IG, Evans E, Brown MR, Gilbert P. Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin. J Antimicrobiol Chemother. 1992; 30: 803-810. (Pubitemid 23040963)
37. Casadevall A, Pirofski LA. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol. 2003; 1: 17-24.
38. Pirofski LA, Casadevall A. What is a pathogen? A question that begs the point. BMC Biol. 2012; 10: 6.